SCHEMBL18256166

SCHEMBL18256166

CCC(=O)N1CCC2(CC(C(C)C)C2)C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 4/20 0.42
ALDH1A1 P00352 3/20 0.39
CYP2D6 P10635 4/20 0.37
CYP2C9 P11712 2/20 0.37
CYP1A2 P05177 1/20 0.37
OPRL1 P41146 3/20 0.36
TSHR P16473 2/20 0.35
CYP2C19 P33261 1/20 0.35
CHRM4 P08173 1/20 0.34
CHRM1 P11229 1/20 0.34
CHRNB2 P17787 2/20 0.34
CHRNA3 P32297 2/20 0.34
CHRNA4 P43681 2/20 0.34
CHRNB3 Q05901 1/20 0.34
CHRNA6 Q15825 1/20 0.34
CYP3A4 P08684 2/20 0.34
HSD11B1 P28845 2/20 0.33
CHRNB4 P30926 1/20 0.33
CHRNA7 P36544 1/20 0.33
HIF1A Q16665 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21765702 0.85 OPRM1 (0.53) OPRM1ALDH1A1CYP2D6CYP2C9CYP1A2
SCHEMBL18256186 0.82 CYP3A4 (0.43) OPRM1ALDH1A1CYP2D6CYP2C9CYP1A2
SCHEMBL25703446 0.79 ALDH1A1 (0.53) OPRM1ALDH1A1CYP2D6CYP2C9CYP1A2
SCHEMBL15998890 0.79 OPRM1 (0.51) OPRM1ALDH1A1OPRL1CHRNB2CHRNA3
SCHEMBL16589307 0.79 OPRM1 (0.43) OPRM1ALDH1A1CYP2D6CYP2C9CYP1A2
SCHEMBL18253214 0.79 BTK (0.36) ALDH1A1CYP2D6CYP2C9CYP1A2TSHR
SCHEMBL617485 0.78 OPRM1 (0.51) OPRM1ALDH1A1CYP2D6CYP2C9CYP1A2
SCHEMBL21765703 0.78 OPRM1 (0.47) OPRM1ALDH1A1CYP2D6CYP2C9CYP1A2
SCHEMBL21303477 0.78 BTK (0.39) ALDH1A1CYP2D6CYP2C9CYP1A2HRH3
SCHEMBL16074977 0.78 BTK (0.39) ALDH1A1CYP2D6CYP2C9CYP1A2HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160340339-A1 PYRAZOLE COMPOUNDS AS BTK INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2016-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160340339-A1 PYRAZOLE COMPOUNDS AS BTK INHIBITORS BTK, SYK, LYN OPRM1 4783/4885ALDH1A1 3342/4885CYP2D6 930/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.